A Phase 3, Randomized, Double-Blind, Multicenter Study Comparing Oral MLN9708 Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma
收藏DataCite Commons2026-04-09 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00007113/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to provide continued access to ixazomib and/or lenalidomide to
participants who are continuing to have clinical benefit and to continue collecting relevant
safety data to monitor safety in participants with Newly Diagnosed Multiple Myeloma (NDMM)
who are not eligible for stem cell transplant.
提供机构：
Vivli
创建时间：
2021-05-06
